DUOX1 and lung carcinoma: Based on previous studies indicating DUOX1 silencing in lung cancers and its impact on resistance to EGFR tyrosine kinase inhibitors9, we evaluated basal activity and subcellular localization of EGFR within various lung cancer cell lines in relation to DUOX1 expression.